Quarterly Results

  • Company Name :
Glenmark Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532296
  • NSE Symbol:
  • GLENMARK
  • P/E(TTM):
  • 37.35
  • ISIN Demat:
  • INE935A01035
  • Div & Yield%:
  • 0.13
  • EPS(TTM):
  • 52.14
  • Book Value(₹):
  • 848.31
  • Market Cap(₹Cr.):
  • 54,951.55
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 1,219.53 2,178.90 1,909.94
Excise Duty 0.00 0.00 0.00
Net Sales 1,219.53 2,178.90 1,909.94
Other Operating Income 319.13 216.03 99.56
Other Income 285.76 69.34 88.45
Total Income 1,824.42 2,464.26 2,097.95
Total Expenditure 2,648.45 1,990.00 1,848.13
PBIDT -824.04 474.26 249.81
Interest 23.40 15.46 13.13
PBDT -847.43 458.80 236.68
Depreciation 58.93 57.64 55.53
Tax -70.17 70.17 -25.62
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -97.01 0.77 59.02
Reported Profit After Tax -739.19 330.23 147.76
Extra-ordinary Items -931.79 -266.07 -120.80
Adjusted Profit After Extra-ordinary item 192.60 596.30 268.56
EPS (Unit Curr.) -26.19 11.70 5.24
EPS (Adj) (Unit Curr.) -26.19 11.70 5.24
Calculated EPS (Unit Curr.) -26.19 11.70 5.24
Calculated EPS (Adj) (Unit Curr.) -26.19 11.70 5.24
Calculated EPS (Ann.) (Unit Curr.) -104.78 46.81 20.94
Calculated EPS (Adj) (Ann.) (Unit Curr.) -104.78 46.81 20.94
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 28.22 28.22 28.22
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) -67.57 21.77 13.08
PBDTM(%) -69.49 21.06 12.39
PATM(%) -60.61 15.16 7.74